|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | INT-767 improves histopathological features in a dietinduced ob/ob mouse model of biopsy-confirmed nonalcoholic steatohepatitis显示文摘AIM To characterize the efficacy of the dual FXR/TGR5 receptor agonist INT-767 upon histological endpoints in a rodent model of diet-induced and biopsy-confirmed non-alcoholic steatohepatitis(NASH).METHODS The effects of INT-767 on histological features of NASH were assessed in two studies using Lep^(ob/ob)(ob/ob) NASH mice fed the AMLN diet(high fat with transfat, cholesterol and fructose). In a proof-of-conceptstudy, Lep^(ob/ob)(ob/ob) NASH mice were first dosed with INT-767(3 or 10 mg/kg for 8 wk). A second ob/ob NASH study compared INT-767(3 and 10 mg/kg) to obeticholic acid(OCA)(10 or 30 mg/kg; 16 wk). Primary histological endpoints included qualitative and quantitative assessments of NASH. Other metabolic and plasma endpoints were also assessed. A comparative assessment of INT-767 and OCA effects on drug distribution and hepatic gene expression was performed in C57 Bl/6 mice on standard chow. C57 Bl/6 mice were orally dosed with INT-767 or OCA(1-30 mg/kg) for 2 wk, and expression levels of candidate genes were assessed by RNA sequencing and tissue drug levels were measured by liquid chromatography tandem-mass spectrometry.RESULTS INT-767 dose-dependently(3 and 10 mg/kg, PO, QD, 8 wk) improved qualitative morphometric scores on steatohepatitis severity, inflammatory infiltrates and fibrosis stage. Quantitative morphometric analyses revealed that INT-767 reduced parenchymal collagen area, collagen fiber density, inflammation(assessed by Galectin-3 immunohistochemistry) and hepatocyte lipid droplet area following INT-767 treatment. In a comparative study(16 wk), the FXR agonists OCA(10 and 30 mg/kg) and INT-767(3 and 10 mg/kg) both improved NASH histopathology, with INT-767 exerting greater therapeutic potency and efficacy than OCA. Mechanistic studies suggest that both drugs accumulate similarly within the liver and ileum, however, the effects of INT-767 may be driven by enhanced hepatic, but not ileal, FXR function. CONCLUSION These findings confirm the potential utility of FXR and dual FXR/TGR5 activation as disease intervention strategies in NASH. | Jonathan D Roth Michael Feigh Sanne S Veidal Louise KD Fensholdt Kristoffer T Rigbolt Henrik H Hansen Li C Chen Mathieu Petitjean Weslyn Friley Niels Vrang Jacob Jelsing Mark Young | 2018 | World Journal of Gastroenterology2018，24，2： | 7 |
| 2 | Metabolic and hepatic effects of liraglutide,obeticholic acid and elafibranor in diet-induced obese mouse models of biopsy-confirmed nonalcoholic steatohepatitis显示文摘AIM To evaluate the pharmacodynamics of compounds in clinical development for nonalcoholic steatohepatitis(NASH) in obese mouse models of biopsy-confirmedNASH.METHODS Male wild-type C57 BL/6 J mice(DIO-NASH) and Lep^(ob/ob)(ob/ob-NASH) mice were fed a diet high in trans-fat(40%), fructose(20%) and cholesterol(2%) for 30 and 21 wk, respectively. Prior to treatment, all mice underwent liver biopsy for confirmation and stratification of liver steatosis and fibrosis, using the nonalcoholic fatty liver disease activity score(NAS) and fibrosis staging system. The mice were kept on the diet and received vehicle, liraglutide(0.2 mg/kg, SC, BID), obeticholic acid(OCA, 30 mg/kg PO, QD), or elafibranor(30 mg/kg PO, QD) for eight weeks. Within-subject comparisons were performed on changes in steatosis, inflammation, ballooning degeneration, and fibrosis scores. In addition, compound effects were evaluated by quantitative liver histology, including percent fractional area of liver fat, galectin-3, and collagen 1 a1.RESULTS Liraglutide and elafibranor, but not OCA, reduced body weight in both models. Liraglutide improved steatosis scores in DIO-NASH mice only. Elafibranor and OCA reduced histopathological scores of hepatic steatosis and inflammation in both models, but only elafibranor reduced fibrosis severity. Liraglutide and OCA reduced total liver fat, collagen 1 a1, and galectin-3 content, driven by significant reductions in liver weight. The individual drug effects on NASH histological endpoints were supported by global gene expression(RNA sequencing) and liver lipid biochemistry.CONCLUSION DIO-NASH and ob/ob-NASH mouse models show distinct treatment effects of liraglutide, OCA, and elafibranor, being in general agreement with corresponding findings in clinical trials for NASH. The present data therefore further supports the clinical translatability and utility of DIO-NASH and ob/ob-NASH mouse models of NASH for probing the therapeutic efficacy of compounds in preclinical drug development for NASH. | Kirstine S Tolbol Maria NB Kristiansen Henrik H Hansen Sanne S Veidal Kristoffer TG Rigbolt Matthew P Gillum Jacob Jelsing Niels Vrang Michael Feigh | 2018 | World Journal of Gastroenterology2018，24，2： | 5 |
| 3 | Towards a standard diet-induced and biopsy-confirmed mouse model of non-alcoholic steatohepatitis: Impact of dietary fat source显示文摘BACKGROUND The trans-fat containing AMLN(amylin liver non-alcoholic steatohepatitis,NASH)diet has been extensively validated in C57BL/6J mice with or without the Lep^ob/Lep^ob(ob/ob)mutation in the leptin gene for reliably inducing metabolic and liver histopathological changes recapitulating hallmarks of NASH.Due to a recent ban on trans-fats as food additive,there is a marked need for developing a new diet capable of promoting a compatible level of disease in ob/ob and C57BL/6J mice.AIM To develop a biopsy-confirmed mouse model of NASH based on an obesogenic diet with trans-fat substituted by saturated fat.METHODS Male ob/ob mice were fed AMLN diet or a modified AMLN diet with trans-fat(Primex shortening)substituted by equivalent amounts of palm oil[Gubra amylin NASH,(GAN)diet]for 8,12 and 16 wk.C57BL/6J mice were fed the same diets for 28 wk.AMLN and GAN diets had similar caloric content(40%fat kcal),fructose(22%)and cholesterol(2%)level.RESULTS The GAN diet was more obesogenic compared to the AMLN diet and impaired glucose tolerance.Biopsy-confirmed steatosis,lobular inflammation,hepatocyte ballooning,fibrotic liver lesions and hepatic transcriptome changes were similar in ob/ob mice fed the GAN or AMLN diet.C57BL/6J mice developed a mild to moderate fibrotic NASH phenotype when fed the same diets.CONCLUSION Substitution of Primex with palm oil promotes a similar phenotype of biopsyconfirmed NASH in ob/ob and C57BL/6J mice,making GAN diet-induced obese mouse models suitable for characterizing novel NASH treatments. | Michelle L Boland Denise Oro Kirstine S T■lb■l Sebastian T Thrane Jens Christian Nielsen Taylor S Cohen David E Tabor Fiona Fernandes Andrey Tovchigrechko Sanne S Veidal Paul Warrener Bret R Sellman Jacob Jelsing Michael Feigh Niels Vrang James L Trevaskis Henrik H Hansen | 2019 | World Journal of Gastroenterology2019，25，33： | 3 |
| 4 | Postnatal development of the autonomic and sensory innervation of the musculature in the rat urinary bladder显示文摘 | Sann H Walb G Pierau FK | 1997 | Neurosci Lett1997，236，1： | 1 |
| 5 | Growth behavior of number distributed adherent MDCK cells for optimization in microcarrier cultures 显示文摘 | Bock A Sann H Schulze-Horsel J | 2009 | Biotechnology Progress2009，25，6： | 1 |
| 6 | Opportunities and challenges for HIV care in overlapping HIV and TB epidemics 显示文摘 | Havlir DV Getahun H Sanne I | 2008 | JAMA2008，300，： | 1 |
| 7 | Opportunities and challen- ges for HIV care in overlapping HIV and TB epidemics显示文摘 | HavlirDV Getahun H Sanne 1 | 2008 | JAMA2008，300，4： | 1 |
| 8 | Mathematical model of influenza a virus production in Large- Scale microcarrier culture显示文摘 | MOHLER L FLOCKERZI D SANN H | 2005 | Biotechnology and Bioengineering2005，90，： | 1 |
| 9 | Severe hepatotoxicity associated with nevirapine use in HIV - infected subjects显示文摘 | Sanne I Mommeja Matin H Hinkle J | 2005 | J Infect Dis2005，191，6： | 1 |
| 10 | Cell surface antigens in renal tumour cells:detection by immunoluminescence and enzymatic analysis显示文摘 | Gohring B Sann H | 2001 | Br J Cancer2001，85，6： | 1 |
| 11 | Opportunities and challenges for HIV care in overlapping HIV and TB epidemics显示文摘 | HAVLIR D V GETAHUN H SANNE I | 2008 | JAMA2008，300，4： | 1 |
| 12 | Rela- tive embryo toxicity of two classes of chemicals in a modified zebrafish embryo toxicity test and comparison with their in vivo potencies 显示文摘 | Sanne A B H Evert-Jan van den B Leo T M | 2011 | Toxicology in Vitro2011，25，： | 1 |
| 13 | Severe heptotoxicity associated with nevirapine use in HIV-infcted subjects显示文摘 | Sanne I Mommeja-Marin H Hinkle J | 2005 | J Infect Dis2005，191，6： | 1 |
| 14 | Formation of defect bands in high pressure die cast magnesium alloys 显示文摘 | Dahle A K Sannes S John D H S | 2001 | JLM2001，1，5： | 1 |
| 15 | Living kidney donors' long-term psychological status and health behavior after nephrectomy- a retrospective study 显示文摘 | Jordan J Sann U Janton A Gossmann J Kramer W Kachel H G | 2004 | J Nephrol2004，17，： | 1 |
| 16 | Opportunities and challenges for HIV care in overlapping HIV and TB epidemics显示文摘 | Havlir DV Getahun H Sanne I et ol | 2008 | JAMA2008，300，4： | 1 |
| 17 | Liquid circulation, bubble size distributions, and solids movement in two- and three- phase bubble columns显示文摘 | Grevskott S Sannes B H Dudukovic M P | 1996 | Chemical Engineering Science1996，51，10： | 1 |
| 18 | Growth behavior of number distributed adherent MDCK cells for optimization in microcarrier cultures 显示文摘 | Bock A Sann H Schulze-Horse J | 2009 | Biotechnol Prog2009，25，6： | 1 |
| 19 | Opportunities and challenges for HIV care in overlapping HIV and TB epidemics 显示文摘 | Havlir DV Getahun H Sanne I | 2008 | JAMA2008，300，4： | 1 |
| 20 | Growth behavior of number distributed adherent MDCK cells for optimization in microcartier cultures显示文摘 | BOCK A SANN H SCHULZE-HORSEL J | | Biotechnol Prog0，25，6： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员